Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.

by Alice Clément-Zhao, Marie-Laure Tanguy, Paul Cottu, Brigitte De La Lande, Patrick Bontemps, Claire Lemanski, Pierre Baumann, Alexia Savignoni, Christelle Levy, Karine Peignaux, Agnès Reynaud-Bougnoux, Aline Gobillion, Youlia Kirova
Published 2019-01-01